Effient trial by Daiichi, Lilly fails to meet primary endpoint

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...Read more

Astellas Pharma opens office in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2013

Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...Read more

A*STAR, GSK develop medicines for emerging markets

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-y...Read more

Aussie firm gets TGA approval for pancreatic cancer drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Good...Read more

Pharmaxis gets grants for fibrotic research

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University o...Read more

Regenerative Therapy for heart failure enters Ph III Trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Belgian biotechnology company Cardio3 BioSciences (C3BS) has received authorization from the Belgian Federal ...Read more

Mesoblast to set up stem cell drug plant in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2014

Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...Read more

Sanford-Burnham, Daiichi form new alliance

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...Read more

Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and saf...Read more

Taiwan firm NCE to get priority review in China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into ...Read more

Astrazeneca, China university in research deal

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic instit...Read more

Phylogica extends collaboration with Janssen Biotech

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...Read more

AstraZeneca, BMS gets positive regulatory feedback on Type 2 diabetes drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided Ast...Read more

Regeneron acquires Sanofi eye care antibodies

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 May, 2013

Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from San...Read more

Teva, Xenon enter $335 mn deal for pain drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative dev...Read more

Linaclotide phase III trial initiated in China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...Read more

Singapore firm, Stehlin Foundation collaborate on anti-cancer drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2013

Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement ...Read more

AseaCyte gets BioSpectrum award for drug discovery efforts

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...Read more